The Study of CM326 in Moderate-to-severe Atopic Dermatitis

Clinical trial NCT05671432 · UNKNOWN

Trial details

NCT number: NCT05671432
Sponsor: Keymed Biosciences Co.Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate-to-severe Atopic Dermatitis

Start date: 2022-12-27
Primary completion: 2023-12-30
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.